Debyani Chakravarty

@CDebyaniPhD

Lead Scientist cancer biologist dedicated to the mission of achieving precision oncology. Tweets are my own.

New York, NY
Vrijeme pridruživanja: lipanj 2016.
136 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @CDebyaniPhD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CDebyaniPhD

  1. prije 13 sati

    Attended faculty orientation hosted by office of the P-in-C. Hung out w/ & w/ leadership Drs. Craig Thompson, Lisa DeAngelis, , Pete Stetson & Laura Lieberman. Yes I’m name dropping! A great way to welcome new investigators!

    11 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    4. velj

    Among persons with H. pylori infection who had a family history of gastric cancer in first-degree relatives, H. pylori eradication treatment reduced the risk of gastric cancer.

    1 reply 13 proslijeđenih tweetova 34 korisnika označavaju da im se sviđa
    Poništi
  3. 4. velj

    Great summer opportunity department for high school/college students: . These are paid opportunities I wish I'd known about when I was a kid (ugh..."when I was a kid"). Learn about different career options in health care & get paid doing it!

    4 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  4. proslijedio/la je Tweet
    30. sij

    It's a small addition, but the new pencil icon allows you to quickly edit and update genes and query criteria (via OQL), in your cBioPortal queries.

    5 proslijeđenih tweetova 33 korisnika označavaju da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    29. sij

    What does a day as the MSK Physician-in-Chief look like? We followed along with Dr. DeAngelis to get an inside look at what a day in her shoes is like and what she sees for MSK moving forward.

    6 proslijeđenih tweetova 31 korisnik označava da mu se sviđa
    Poništi
  6. 29. sij

    ⁦⁩ delivering his annual tour de force “State of the ⁦⁦⁩” - galvanizing his people!

    2 proslijeđena tweeta 29 korisnika označava da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    28. sij

    In this paper; investigators evaluate Raf inhibitor in V600E and non V600E mutant nsclc, and reinforce the concept that a companion diagnostic should meet a precise definition and not only "raf mutated" cancer.

    article reporting on the cohort of BRAF-mutated NSCLC treated with Vemurafenib in the AcSé trial
    18 proslijeđenih tweetova 23 korisnika označavaju da im se sviđa
    Poništi
  8. proslijedio/la je Tweet
    28. sij

    Out of all the Kobe stories in the last day, this one hit differently. Elle Duncan on Kobe “being a dad. A girl dad.”

    69.155 proslijeđenih tweetova 299.896 korisnika označava da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    27. sij

    Thanks to for an enlightening talk in Dublin Defining the Actionable Genome including discussion re next generation . Highlighting work of and others.

    6 proslijeđenih tweetova 33 korisnika označavaju da im se sviđa
    Poništi
  10. 24. sij

    I don't know if I like the new interface. It will take some time to get used to - change is hard .

    4 korisnika označavaju da im se sviđa
    Poništi
  11. 24. sij

    lotsa❤️ to these kids:Trekking after school to from Brooklyn Latin every Wed to learn abt Cancer Biology(w/ instructors like me, & pic'd here Dr. Jose Reyes) via SEP HOPP by & Emily Delgado

    1 reply 3 proslijeđena tweeta 46 korisnika označava da im se sviđa
    Poništi
  12. 16. sij

    Excellent talks & lively discussion at the initiative led by our intrepid PIC Lisa DeAngelis w/ & leading the 1st series lecture. A great start w/dialogue, ideas & humor: science doesn’t exist in a silo here!

    1 proslijeđeni tweet 16 korisnika označava da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    16. sij

    Today my most excellent GYN medical oncology colleagues visited at the Joy building. A great addition to the phone booth wall of fame !

    1 reply 2 proslijeđena tweeta 22 korisnika označavaju da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    16. sij

    In the January issue of Cancer Discovery, John Kwon and review the cytosolic DNA-sensing cGAS–STING pathway in .

    21 proslijeđeni tweet 30 korisnika označava da im se sviđa
    Poništi
  15. 15. sij

    Superb PRSS talk hosted by by Dr. Shelley Berger from U Penn. elegant studies demonstrating the role of SIRT1, LADS and LaminB1 histone marks in aging and Alzheimer’s disease. The biochemical expts were beautiful!

    2 proslijeđena tweeta 13 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    1. stu 2019.

    Application portal now open for undergrad summer research internships at & . Tell your students! tell your kids! apply before 2/1/20! Website for more information on all summer programs:

    Korisnici , i
    44 proslijeđena tweeta 48 korisnika označava da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    14. sij

    Larotrectinib shows impressive clinical efficacy in NTRK fusion positive NSCLC! Highlights from our poster presented at shown here. NTRK fusions should be included in molecular screening panels - must not miss!

    1 reply 42 proslijeđena tweeta 118 korisnika označava da im se sviđa
    Poništi
  18. 14. sij

    Several case series hv shown MET ex14 splice mt in NSCLC as predictive of crizotinib activity, it’s listed & a Level 2 mt. Hoping this prospective clinical study by EDD Chief FINALLY gets MET ex14 mt listed in crizotinib’s label!

    Our paper is out today! Crizotinib is the first MET inhibitor to prospectively show activity in METex14-altered NSCLC, is widely available, and is in the NCCN guidelines for this indication. A great treatment option while we wait for the potential approval of a selective MET TKI.
    1 proslijeđeni tweet 7 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    13. sij

    Delighted to share our paper on the regenerative origin of in the inaugural issue of ! Tremendous thanks to , colleagues and patients who enabled models of

    🚨: Cancer metastasis and wound healing have more in common than you might think. New research from SKI suggests that metastatic cells co-opt the body’s natural wound-healing abilities to spread.
    20 replies 63 proslijeđena tweeta 229 korisnika označava da im se sviđa
    Poništi
  20. proslijedio/la je Tweet
    13. sij

    Kudos to for thinking, managing and pushing thru the finish line our new work now out in Nat Gen. She is more than ready to run her lab. and more. Here is the link and a tweetorial

    15 proslijeđenih tweetova 68 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi

@CDebyaniPhD još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·